Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Depreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization EBIAT Leases Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

Alx Oncology Holdings (ALXO) Preferred Shares Issued (2019 - 2020)

Alx Oncology Holdings' Preferred Shares Issued history spans 2 years, with the latest figure at -$311000.0 for Q2 2020.

On a quarterly basis, Preferred Shares Issued changed N/A to -$311000.0 in Q2 2020 year-over-year; TTM through Dec 2020 was $104.7 million, a N/A change, with the full-year FY2020 number at $104.7 million, up 1010.07% from a year prior.
Preferred Shares Issued hit -$311000.0 in Q2 2020 for Alx Oncology Holdings, down from $105.0 million in the prior quarter.
Over the last five years, Preferred Shares Issued for ALXO hit a ceiling of $105.0 million in Q1 2020 and a floor of -$311000.0 in Q2 2020.